EFFECTS OF PROSTAGLANDIN-E2 AND PROSTAGLANDIN-F2ALPHA UPON URINARY KALLIKREIN EXCRETION IN RATS
| dc.contributor.author | CROXATTO, HR | |
| dc.contributor.author | ARRIAGADA, R | |
| dc.contributor.author | ROJAS, M | |
| dc.contributor.author | ROBLERO, J | |
| dc.contributor.author | ROSAS, R | |
| dc.date.accessioned | 2025-01-23T19:44:52Z | |
| dc.date.available | 2025-01-23T19:44:52Z | |
| dc.date.issued | 1978 | |
| dc.fuente.origen | WOS | |
| dc.identifier.issn | 0301-0538 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/100144 | |
| dc.identifier.wosid | WOS:A1978GF20000041 | |
| dc.language.iso | en | |
| dc.pagina.final | S189 | |
| dc.pagina.inicio | S187 | |
| dc.revista | Clinical science and molecular medicine | |
| dc.rights | acceso restringido | |
| dc.subject.ods | 03 Good Health and Well-being | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.title | EFFECTS OF PROSTAGLANDIN-E2 AND PROSTAGLANDIN-F2ALPHA UPON URINARY KALLIKREIN EXCRETION IN RATS | |
| dc.type | artículo | |
| dc.volumen | 55 | |
| sipa.index | WOS | |
| sipa.trazabilidad | WOS;2025-01-12 |
